Efficacy News and Research

RSS

Many people infected with SARS-CoV-2 Omicron didn't realize it

A recent study reports on the awareness level among individuals during the recent Omicron variant surge.

22 Aug 2022

Hydrogen peroxide kills 99.99% of SARS-CoV-2 on fabrics in 30 seconds

Three percent hydrogen peroxide eliminates 99.9% of SARS-CoV-2 in all types of tested fabrics within 30 seconds.

22 Aug 2022

Modified TB vaccine could help treat non-muscle invasive bladder cancer

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

22 Aug 2022

“Drug factory” implants show promise in eradicating mesothelioma tumors

Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and a checkpoint inhibitor drug.

22 Aug 2022

World's first-in-human research using organoid transplantation yields good results

Tokyo Medical and Dental University (TMDU) research team announced on July 7 that it has succeeded in the world's first clinical transplantation of a "mini organ (also called Organoid)" into a patient with "Ulcerative Colitis (UC)".

22 Aug 2022

Tiny, touch-based sensor rapidly detects lithium levels from sweat on the surface of a fingertip

Lithium can alleviate the symptoms of bipolar disorder and depression - if taken in just the right amount.

22 Aug 2022

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Researchers explored how effectively nanotechnology-based novel and potential vaccines, drugs, and monoclonal antibodies could combat the current and yet to emerge SARS-CoV-2 variants.

22 Aug 2022

Research reveals cetylpyridinium chloride in mouthwash shows anti-SARS-CoV-2 effects

A recent study has demonstrated the antiviral effectiveness of cetylpyridinium chloride against SARS-CoV-2 infection.

22 Aug 2022

Study shows rapid waning of immune protection due to prior BA.1/BA.2 infection against BA.5 breakthrough infection

Researchers investigated the waning of protective immunity conferred by prior infection by Omicron sub-variants BA.1, BA.2 towards its most recent sub-variant BA.5.

22 Aug 2022

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Researchers conducted a phase III clinical trial to test the effectiveness of three repurposed drugs - metformin, ivermectin, and fluvoxamine, in preventing progression to severe COVID-19.

22 Aug 2022

Durability of immune protection after booster immunization with COVID-19 adjuvanted subunit vaccine against the immune-evasive Omicron BA.1 variant

Researchers explored the durability of immunity imparted by the SARS-CoV-2 adjuvanted subunit vaccine against the Omicron variant.

22 Aug 2022

Day-of-injury blood tests predict which TBI patients are likely to die or survive with severe disability

A study finds that blood tests taken the day of a traumatic brain injury can predict which patients are likely to die or survive with severe disability, allowing clinicians to make decisions earlier on possible treatment of TBI.

19 Aug 2022

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Researchers assessed the SARS-CoV-2 variants of concern (VOCs) transmission dynamics and neutralization by vaccine-induced antibodies and monoclonal antibodies (mAbs).

19 Aug 2022

Researchers provide comprehensive review of human monkeypox infections

In a new study, researchers reviewed the various aspects of human monkeypox infections.

19 Aug 2022

Bioengineered corneal tissue implantation restores vision in advanced keratoconus

In a new study, researchers bioengineered corneal tissue for minimally invasive vision restoration.

18 Aug 2022

How do BNT162b2 vaccine-induced neutralizing and non-neutralizing antibodies synergize to promote protection against SARS-CoV-2?

Scientists explored the COVID-19 BNT162b2 vaccine triggered non-neutralizing and neutralizing antibody functions.

18 Aug 2022

Efficacy News and Research

Many people infected with SARS-CoV-2 Omicron didn't realize it

Hydrogen peroxide kills 99.99% of SARS-CoV-2 on fabrics in 30 seconds

Modified TB vaccine could help treat non-muscle invasive bladder cancer

“Drug factory” implants show promise in eradicating mesothelioma tumors

World's first-in-human research using organoid transplantation yields good results

Tiny, touch-based sensor rapidly detects lithium levels from sweat on the surface of a fingertip

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Research reveals cetylpyridinium chloride in mouthwash shows anti-SARS-CoV-2 effects

Study shows rapid waning of immune protection due to prior BA.1/BA.2 infection against BA.5 breakthrough infection

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Durability of immune protection after booster immunization with COVID-19 adjuvanted subunit vaccine against the immune-evasive Omicron BA.1 variant

Day-of-injury blood tests predict which TBI patients are likely to die or survive with severe disability

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Researchers provide comprehensive review of human monkeypox infections

Bioengineered corneal tissue implantation restores vision in advanced keratoconus

How do BNT162b2 vaccine-induced neutralizing and non-neutralizing antibodies synergize to promote protection against SARS-CoV-2?

Eating grapes may reduce the risk of fatty liver disease

Study contributes to better understanding of the changes in kinase activity in renal cell carcinoma

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

Can evolutionary principles lead to new treatments or vaccines for monkeypox?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News